Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Radiology & imaging · First Medical Center of the Chinese PLA General Hospital · Beijing

Dr. Liu Fengyong刘凤永

Chief Physician · Professor
Deputy department head

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

LF

Professional overview

Chief Physician and Professor at First Medical Center of the Chinese PLA General Hospital, specializing in interventional radiology for malignant and benign tumors, vascular diseases, and obstructive conditions.

SpecialtyRadiology & imaging
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor
DepartmentDepartment of Interventional Radiology
HospitalFirst Medical Center of the Chinese PLA General Hospital
CityBeijing
Hospital roleDeputy Director, Department of Interventional Radiology

Department leadership

Deputy department head

A department head is an organisational role. “Chief Physician” is a clinical rank; the two are listed separately.

Areas of focus

Transarterial chemoembolization (TACE)Used for primary liver cancer, liver metastases, and other malignancies; combined with radiofrequency ablation or radioactive particle implantation under DSA-CT fusion guidance for large or giant hepatocellular carcinoma.
Radiofrequency ablation (RFA)Applied to primary liver cancer, liver metastases, pancreatic cancer, lung cancer, cervical cancer, renal cancer, adrenal tumors, bladder and prostate cancer, hepatic hemangioma, focal nodular hyperplasia (FNH), hepatocellular adenoma, uterine fibroids, splenomegaly with hypersplenism, and renal angiomyolipoma.
Radioactive particle implantationUsed for refractory primary or metastatic lung cancer, large or giant hepatocellular carcinoma, and portal vein tumor thrombus, inferior/superior vena cava tumor thrombus, hepatic vein tumor thrombus, and retroperitoneal lymph node metastases.
Percutaneous biopsyPerformed for pulmonary, hepatic, retroperitoneal, and bone tumors.
Interventional therapy for thrombosis and stenosisTreats portal-mesenteric venous thrombosis, Budd-Chiari syndrome, limb and pelvic venous thrombosis, pulmonary embolism, dialysis access thrombosis/stenosis, and other arterial/venous thrombotic, stenotic, or malformative conditions.
Interventional therapy for stricturesAddresses biliary, airway, esophageal, and gastrointestinal strictures.
Emergency interventional therapy for massive hemorrhageIncludes transjugular intrahepatic portosystemic shunt (TIPS) and other procedures.

Background

  • 2013Senior Visiting Scholar, Department of Interventional Radiology, MD Anderson Cancer Center, USA
  • 2014Postdoctoral Fellow, Division of Interventional Radiology, Massachusetts General Hospital, Harvard Medical School, USA

Experience & recognition

  • Principal investigator of 2 National Natural Science Foundation of China (NSFC) general projects
  • Principal investigator of 1 military Twelfth Five-Year Plan key project
  • Principal investigator of 1 Beijing Municipal Science and Technology New Star project
  • Principal investigator of 1 Beijing Natural Science Foundation project
  • Principal investigator of 1 China Anti-Cancer Association project
  • Editorial board member or reviewer for multiple journals including Chinese Journal of Radiology, Journal of Interventional Radiology, Chinese Journal of Oncology, Chinese Journal of Hepatobiliary Surgery, and Chinese Journal of Medical Imaging
  • National Science Fund for Distinguished Young Scholars recipient
  • State Council Special Allowance recipient

Professional roles

  • Vice Chair and Secretary-General, Interventional Diagnosis and Treatment Society, China International Exchange and Promotive Association for Medical and Health Care (CPAM)
  • Vice Chair, Molecular Diagnostic Medicine Professional Committee, Chinese Research Hospital Association
  • Vice Chair, Beijing Health Promotion Association Liver Cancer Intervention Expert Committee
  • Standing Committee Member, Tumor Minimally Invasive Intervention Professional Committee, Chinese Research Hospital Association
  • Vice Chair, Youth Committee, Mobile Healthcare Professional Committee, Chinese Research Hospital Association
  • Member, Contrast Media Study Group, Chinese Medical Association (CMA) Radiological Society
  • Member, New England Society of Interventional Radiology, USA
  • Reviewer, National Natural Science Foundation of China (NSFC)

Frequently asked questions

What does Dr. Liu Fengyong specialize in?

Specializes in comprehensive interventional treatment of malignant tumors (e.g., primary liver cancer, liver metastases, pancreatic cancer, lung cancer, cervical cancer, renal cancer, adrenal tumors, bladder and prostate cancer), benign tumors (e.g., hepatic hemangioma, focal nodular hyperplasia, hepatocellular adenoma, uterine fibroids, splenomegaly with hypersplenism, renal angiomyolipoma), tumor-related complications (e.g., portal vein tumor thrombus, vena cava tumor thrombus), vascular diseases (e.g., thrombosis, stenosis, malformation), strictures (e.g., biliary, airway, esophageal, gastrointestinal), and emergency massive hemorrhage — using techniques including TACE, RFA, cryoablation, irreversible electroporation (IRE), radioactive particle implantation, percutaneous biopsy, and TIPS.

Which hospital and department is Dr. Liu Fengyong in?

Department of Interventional Radiology at First Medical Center of the Chinese PLA General Hospital

Sources

Dr. Liu Fengyong has not reviewed this page.